Neumora Therapeutics (NMRA) Depreciation & Amortization (CF) (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Depreciation & Amortization (CF) of $7,000 in Q2 2026, down 63.2% from $19,000 a year earlier and down 12.5% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
On a TTM basis, Neumora Therapeutics' Depreciation & Amortization (CF) came in at $47,000 as of Jun 30, 2026, down 90.4% year-over-year; for FY2025, it came in at $208,000, down 67.0% from FY2024.
- Annual Depreciation & Amortization (CF) has a three-year compound annual growth rate of -29.8% (FY2022 to FY2025).
- Across earlier years, Depreciation & Amortization (CF) came in at $631,000 in FY2024 (-9.9%), $700,000 in FY2023 (+16.7%) and $600,000 in FY2022.
- The Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2022.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined for nine consecutive quarters, with an average decline of 57.1% over the last eight quarters.
- Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 29.4% in Q4 2023, against a decline of 94.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $8,000 (Q1 2026), $9,000 (Q4 2025) and $23,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - | 7,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 158,000.00 |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 173,000.00 |
| Jun 30, 2023 | 171,000.00 |
| Mar 31, 2023 | 158,000.00 |
| Dec 31, 2022 | 153,000.00 |
API Access
Neumora Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();